Anticoagulation use was characterised according to guideline-recommended risk scores and Indigenous status.

Patients were linked to the SA Cancer Registry to obtain Indigenous status.

No differences in discharge arrangements were identified by Indigenous status.

Aim: We aimed to profile ED presentations in the NT involving SRTBs by Indigenous status and compare discharge arrangements.